-
Je něco špatně v tomto záznamu ?
Azone analogues: classification, design, and transdermal penetration principles
J. Jampilek, K. Brychtova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Medline Complete (EBSCOhost)
od 2012-07-01 do Před 1 rokem
Wiley Online Library (archiv)
od 1996-01-01 do 2012-12-31
PubMed
22886628
DOI
10.1002/med.20227
Knihovny.cz E-zdroje
- MeSH
- aplikace kožní MeSH
- azepiny chemie metabolismus farmakologie MeSH
- kožní absorpce účinky léků MeSH
- kůže anatomie a histologie účinky léků MeSH
- kvantitativní vztahy mezi strukturou a aktivitou MeSH
- lidé MeSH
- racionální návrh léčiv * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The development in the field of pharmaceutical dosage forms results in the discovery of additional highly sophisticated drug delivery systems that allow maintaining a constant level of the active substance in an organism. Transdermal therapeutic systems are an excellent alternative to conventional pharmaceutical dosage forms. However, the application of transdermal drug delivery faces the problem of insufficient or no penetration of active pharmaceutical substances through the skin. This review article describes the possible fundamental mechanisms of penetration through the skin barrier and refers to the classification of skin penetration enhancers. Azone-like enhancers are considered in detail and classified according to their structure on the basis of medicinal chemistry approaches. The article also provides a review of original transdermal penetration enhancers prepared in our laboratory and discusses the relationship between the chemical structure of the described Azone analogues and their penetration activity (SAR/QSAR).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024350
- 003
- CZ-PrNML
- 005
- 20130710103019.0
- 007
- ta
- 008
- 130703s2012 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/med.20227 $2 doi
- 035 __
- $a (PubMed)22886628
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jampilek, Josef $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1-3, 612 42 Brno, Czech Republic. josef.jampilek@zentiva.cz
- 245 10
- $a Azone analogues: classification, design, and transdermal penetration principles / $c J. Jampilek, K. Brychtova,
- 520 9_
- $a The development in the field of pharmaceutical dosage forms results in the discovery of additional highly sophisticated drug delivery systems that allow maintaining a constant level of the active substance in an organism. Transdermal therapeutic systems are an excellent alternative to conventional pharmaceutical dosage forms. However, the application of transdermal drug delivery faces the problem of insufficient or no penetration of active pharmaceutical substances through the skin. This review article describes the possible fundamental mechanisms of penetration through the skin barrier and refers to the classification of skin penetration enhancers. Azone-like enhancers are considered in detail and classified according to their structure on the basis of medicinal chemistry approaches. The article also provides a review of original transdermal penetration enhancers prepared in our laboratory and discusses the relationship between the chemical structure of the described Azone analogues and their penetration activity (SAR/QSAR).
- 650 _2
- $a aplikace kožní $7 D000279
- 650 _2
- $a azepiny $x chemie $x metabolismus $x farmakologie $7 D001381
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
- 650 _2
- $a kůže $x anatomie a histologie $x účinky léků $7 D012867
- 650 _2
- $a kožní absorpce $x účinky léků $7 D012869
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Brychtova, Katerina $u -
- 773 0_
- $w MED00003265 $t Medicinal research reviews $x 1098-1128 $g Roč. 32, č. 5 (2012), s. 907-47
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22886628 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130710103442 $b ABA008
- 999 __
- $a ok $b bmc $g 988030 $s 822730
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 32 $c 5 $d 907-47 $i 1098-1128 $m Medicinal research reviews $n Med Res Rev $x MED00003265
- LZP __
- $a Pubmed-20130703